4//SEC Filing
Lippman Evan 4
Accession 0000950170-25-074286
CIK 0000818686other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:00 PM ET
Size
8.1 KB
Accession
0000950170-25-074286
Insider Transaction Report
Form 4
Lippman Evan
EVP, Business Development
Transactions
- Award
Restricted Share Units
2025-05-14+148,016→ 148,016 total→ Ordinary Shares (148,016 underlying) - Award
Restricted Share Units
2025-05-14+47,365→ 47,365 total→ Ordinary Shares (47,365 underlying)
Footnotes (4)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on May 14, 2025 with 11,841 vesting on each of May 14, 2026, May 14, 2027 and May 14, 2028, and 11,842 vesting on May 14, 2029.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F4]Restricted share units were granted on May 14, 2025 with 74,008 vesting on May 14, 2026, and 37,004 vesting on each of May 14, 2027 and May 14, 2028.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0002062834
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:00 PM ET
- Size
- 8.1 KB